NCT07623928Not yet recruiting
Developing a Virtual Reality-assisted Intervention for Emotion Regulation Difficulties in Psychosis
MANaging emOtions in Everyday Life Using Virtual REality (MANOEUVRE): Developing a VR-assisted Intervention for Emotion Regulation Difficulties in Psychosis
Source: ClinicalTrials.gov · Last updated 3 Jun 2026
Brief summary (registry, in English)
Supporting people with psychosis to manage their emotions using virtual reality Many people who have experienced psychosis feel overwhelmed by their emotions. Emotions get in the way of doing what matters to them. They want support to manage emotions differently. There is evidence that people with psychosis find talking therapies that teach skills for managing emotions helpful. People said it helped them to understand and manage their emotions. However, they also wanted more help to apply skills they learned to their lives. It is hard to help people to use therapy skills in real-life situations. Therapists cannot be present when the skills are needed. One solution is to use virtual reality (VR) to bridge the gap between the clinic and real-life. VR involves using a headset to see and hear a very life-like computer-generated simulation of everyday life situations. People with psychosis find VR therapies engaging and helpful. It can feel safer to try things out in VR. Guided by the feedback of people with psychosis, this research will evaluate a novel therapy to help people with psychosis manage their emotions. Face-to- face therapy will be combined with VR so that people can practice emotion regulation skills safely with "live" coaching from a therapist. This should support people to use these skills when they need them. Fifteen people with psychosis will be offered the therapy. Everyone will be asked what they think of it and complete questionnaires before and after therapy to see what impact it had on their lives. A lived experience advisory group will support all aspects of the research process.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 15 (estimated)
- First submitted
- 20 May 2026
- Start date
- 1 Sept 2027
- Primary completion date
- 1 May 2028
- Lead sponsor
- King's College London
- Diseases
- Schizophrenia
- NCT number
- NCT07623928
What you commit to
- Study type: Interventional
- Planned participants: 15
- From 1 Sept 2027 to the primary completion date, 1 May 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- History of photosensitive epilepsy
Other
- Clinical presentation (e.g., immediate serious risk to self) (as assessed by their clinical team)
Who the study is looking for
- Currently under the care of South London and Maudsley (SLaM) National Health Service (NHS) outpatient services.
- Clinical diagnosis of psychosis (schizophrenia spectrum disorder) (as assessed by their clinical team)
- Willing to have the interview audio recorded (if taking part in post therapy interview)
- Willing and able to provide informed consent to participate in the study (as assessed by their clinical team)
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Institute of Psychiatry, Psychology & Neuroscience (IoPPN), King's College London Coordinator of this site? Confirm its status | London | United Kingdom | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.